Back to Search
RIKI KREITMAN, DMD
DMD
General Practice Dentistry
NPI: 1497828974Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DI17437(NJ)
Research & Publications (20)
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.
PMID 19414673·J Clin Oncol·2009
3-trial
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
PMID 19344187·BioDrugs·2009
6-review
Proof of concept studies for tissue-protective agents in multiple sclerosis.
PMID 19389749·Mult Scler·2009
6-review
CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies.
PMID 19188153·Clin Cancer Res·2009
4-observational
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
PMID 18988862·Blood·2009
7-preclinical
Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P.
PMID 19671873·Clin Cancer Res·2009
3-trial
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
PMID 18431797·Cytometry B Clin Cytom·2008
8-other
Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis.
PMID 18208875·Mult Scler·2008
2-rct
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
PMID 17878392·J Immunol·2007
3-trial
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
PMID 17051241·Leukemia·2007
8-other
Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.
PMID 17785569·Clin Cancer Res·2007
3-trial
Immunotoxins in the treatment of hematologic malignancies.
PMID 17073592·Curr Drug Targets·2006
6-review
Immunotoxins in the treatment of refractory hairy cell leukemia.
PMID 16990113·Hematol Oncol Clin North Am·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 34 S 4TH AVE
HIGHLAND PARK, NJ 08904 - Phone
- (732) 572-3226
Quick Facts
- NPI
- 1497828974
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile